Related references
Note: Only part of the references are listed.Glypican-4 is increased in human subjects with impaired glucose tolerance and decreased in patients with newly diagnosed type 2 diabetes
Ke Li et al.
ACTA DIABETOLOGICA (2014)
The influence of endocannabinoid receptor 1 gene variations on anthropometric and metabolic parameters of women with polycystic ovary syndrome
Agnieszka Lenarcik-Kabza et al.
ENDOKRYNOLOGIA POLSKA (2014)
The polycystic ovary syndrome: a position statement from the European Society of Endocrinology
Gerard Conway et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2014)
Hyperandrogenemia Predicts Metabolic Phenotype in Polycystic Ovary Syndrome: The Utility of Serum Androstenedione
Michael W. O'Reilly et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
The Changes of Serum Glypican4 in Obese Patients With Different Glucose Metabolism Status
Hui Juan Zhu et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
Study of carbohydrate metabolism indices and adipocytokine profile and their relationship with androgens in polycystic ovary syndrome after menopause
Marios C. Markopoulos et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2013)
Association of Glypican-4 With Body Fat Distribution, Insulin Resistance, and Nonalcoholic Fatty Liver Disease
H. J. Yoo et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
Glypican-4 is a new comer of adipokines working as insulin sensitizer
Yoshikazu Tamori et al.
JOURNAL OF DIABETES INVESTIGATION (2013)
Cardiovascular Disease Risk Assessment: Insights from Framingham
Ralph B. D'Agostino et al.
GLOBAL HEART (2013)
Glypican-4 Enhances Insulin Signaling via Interaction With the Insulin Receptor and Serves as a Novel Adipokine
Siegfried Ussar et al.
DIABETES (2012)
Systematic review: association of polycystic ovary syndrome with metabolic syndrome and non-alcoholic fatty liver disease
A. Baranova et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2011)
Anthropometric, clinical and laboratory comparison of four phenotypes of polycystic ovary syndrome based on Rotterdam criteria
Mehmet Yilmaz et al.
JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH (2011)
Effect of moderate-intensity exercise on oxidative stress indices in metabolically healthy obese and metabolically unhealthy obese phenotypes in postmenopausal women: a pilot study
Felicja Lwow et al.
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY (2011)
Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis
Lisa J. Moran et al.
HUMAN REPRODUCTION UPDATE (2010)
Adipose Depots Possess Unique Developmental Gene Signatures
Yuji Yamamoto et al.
OBESITY (2010)
The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report
Ricardo Azziz et al.
FERTILITY AND STERILITY (2009)
Abdominal fat quantity and distribution in women with polycystic ovary syndrome and extent of its relation to insulin resistance
Enrico Carmina et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
Evidence for a role of developmental genes in the origin of obesity and body fat distribution
S Gesta et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)
BCJM Fauser et al.
HUMAN REPRODUCTION (2004)
Use and abuse of HOMA modeling
TM Wallace et al.
DIABETES CARE (2004)
Share Paper
